Skip to content

MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback

The MOVES Trial: MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03820024
Acronym
MOVES
Enrollment
39
Registered
2019-01-29
Start date
2018-09-28
Completion date
2020-12-23
Last updated
2021-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer

Brief summary

Overweight and obese endometrial cancer (EC) survivors at the University of North Carolina (UNC) at Chapel Hill will be approached for tailored feedback fitness intervention. The investigators plan to enroll 36 women (18 in each arm) to evaluate if receipt of weekly tailored feedback messages can improve physical activity in EC survivors. It is hypothesized that women receiving the feedback message intervention will increase step counts from baseline more than 2,000 steps compared to women in the non-intervention arm.

Detailed description

Objectives: * To assess if a tailored feedback fitness intervention can increase physical activity in EC survivors from baseline to 12 weeks post-baseline * To determine the acceptability of the fitness intervention in EC survivors through a completion survey. * To assess if a tailored feedback message fitness intervention can (1) decrease BMI, (2) reduce waitst to hip (W.H) ratios, (3) improve quality of life (QOL) and (4) improve serum metabolic markers (insulin, glucose and low density lipoprotein (LDL) in EC survivors.

Interventions

Participants randomized to the message arm will begin receiving encouragement and reminder UNC CHART messages to increase physical activity weekly. Participants on the feedback arm will receive 1 message per week during the 3-month study period.

Sponsors

UNC Lineberger Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be over the age of 18 years * Have a confirmed diagnosis of endometrial cancer and have completed therapy (surgery, chemotherapy or radiation) within the past 6 months * Have no current evidence of endometrial cancer * Have a BMI 25 kg/m2 or greater * Have approval from their treating physician to engage in moderate-intensity physical activity. * Have a smart phone with Bluetooth capabilities turned on * Have access to email

Exclusion criteria

* Are currently undergoing treatment for their cancer * Are unable to read a sample message aloud * Do not have a computer or smart phone with Bluetooth capabilities * Are pregnant * Have a history of angina or palpitations with exertion * Have a history of uncontrolled pulmonary disease (COPD or asthma) * Have one or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention.

Design outcomes

Primary

MeasureTime frameDescription
Change in Steps in Endometrial Cancer Survivors During 12 Week Intervention13 weeksSteps recorded on a fitness tracker at week 1 and week 13

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 9/28/2018 to 12/23/2019

Pre-assignment details

Thirty-nine participants were consented

Participants by arm

ArmCount
Tailored Feedback Messages
Participants randomized to the message arm will begin receiving encouragement and reminder UNC CHART messages to increase physical activity weekly based on the CHART algorithm (Appendix 1). Participants on the feedback arm will receive 1 message per week during the 3-month study period. Tailored Feedback Messages: Participants randomized to the message arm will begin receiving encouragement and reminder UNC CHART messages to increase physical activity weekly. Participants on the feedback arm will receive 1 message per week during the 3-month study period.
18
No Messages
No feedback messages
18
Total36

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision12

Baseline characteristics

CharacteristicTotalTailored Feedback MessagesNo Messages
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants2 Participants2 Participants
Age, Categorical
Between 18 and 65 years
32 Participants16 Participants16 Participants
Age, Continuous55.7 years55.3 years56.4 years
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
32 Participants16 Participants16 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants1 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
9 Participants6 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants2 Participants
Race (NIH/OMB)
White
25 Participants12 Participants13 Participants
Region of Enrollment
United States
36 participants18 participants18 participants
Sex: Female, Male
Female
36 Participants18 Participants18 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 180 / 18
other
Total, other adverse events
0 / 180 / 18
serious
Total, serious adverse events
0 / 180 / 18

Outcome results

Primary

Change in Steps in Endometrial Cancer Survivors During 12 Week Intervention

Steps recorded on a fitness tracker at week 1 and week 13

Time frame: 13 weeks

ArmMeasureValue (MEAN)Dispersion
Tailored Feedback MessagesChange in Steps in Endometrial Cancer Survivors During 12 Week Intervention1037 Change in stepsStandard Error 0.02
No MessagesChange in Steps in Endometrial Cancer Survivors During 12 Week Intervention309 Change in stepsStandard Error 0.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026